Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis

PR Newswire - Press Release

All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here

Study will evaluate drug's potential neuro-restorative mechanism(s) of action for improving synaptic health and cognitive function in MS patients

NEW YORK, July 19, 2023 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq:SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, today announced that it entered into an agreement with Cleveland Clinic to conduct a phase 1 trial of Bryostatin-1 in multiple sclerosis (MS). Cleveland Clinic will manage the clinical trial's implementation, including an Investigational New Drug (IND) submission to the US Food and Drug Administration and patient enrollment.

Read more at prnewswire.com

Related Symbols

Symbol Last Chg %Chg
SNPX 35.00 +1.30 +3.86%
Tradr 2X Long Snps Daily ETF

Most Popular News

A Palantir sign displayed on an office building by Poetra_RH via Shutterstock 1
Palantir: The Future of Defense Contracts or DiamondCluster 2.0? What Michael Burry Has to Say About PLTR Stock.
Image of Mark Zuckerberg by Rokas Tenys via Shutterstock 2
Could Meta Stock Skyrocket in 2026 If Mark Zuckerberg Declares Another ‘Year of Efficiency’?
Chipset held over rush hour traffic by Jae Young Ju via iStock 3
Dear Micron Stock Fans, Mark Your Calendars for December 17
Meta by creativeneko via Shutterstock 4
Is Google Stock a Buy Ahead of Its First AI Glasses Launch?
Federal Reserve Building 2 by Jeremy Edwards via iStock 5
Stock Index Futures Muted Amid Caution Ahead of Fed Rate Decision
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot